You are here

Article info

Article menu
Pharmacology
Original research
Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review

Authors

  • Eleanor Grace Dixon Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK Department of Women’s and Children’s Health, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Charlotte EM Rugg-Gunn Department of Women’s and Children’s Health, University of Liverpool, Liverpool, UK School of Medicine, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Vanessa Sellick Montelukast (Singulair) Side Effects Support and Discussion Group, International Group, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Ian P Sinha Department of Women’s and Children’s Health, University of Liverpool, Liverpool, UK Respiratory Medicine, Alder Hey Children's NHS Foundation Trust, Liverpool, UK PubMed articlesGoogle scholar articles
  • Daniel B Hawcutt Department of Women’s and Children’s Health, University of Liverpool, Liverpool, UK NIHR Alder Hey Clinical Research Facility, Alder Hey Children's Hospital, Liverpool, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Daniel B Hawcutt; dhawcutt{at}liverpool.ac.uk
View Full Text

Citation

Dixon EG, Rugg-Gunn CE, Sellick V, et al
Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review
BMJ Paediatrics Open 2021;5:e001206. doi: 10.1136/bmjpo-2021-001206

Publication history

  • Received June 26, 2021
  • Accepted September 17, 2021
  • First published October 13, 2021.
Online issue publication 
January 18, 2023
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.